These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12870371

  • 1. Impact of side-effects of atypical antipsychotics on non-compliance, relapse and cost.
    Mortimer A, Williams P, Meddis D.
    J Int Med Res; 2003; 31(3):188-96. PubMed ID: 12870371
    [Abstract] [Full Text] [Related]

  • 2. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
    Kongsakon R, Leelahanaj T, Price N, Birinyi-Strachan L, Davey P.
    J Med Assoc Thai; 2005 Sep; 88(9):1267-77. PubMed ID: 16536115
    [Abstract] [Full Text] [Related]

  • 3. Did CATIE influence antipsychotic use?
    Citrome L, Jaffe A, Martello D, Allingham B, Levine J.
    Psychiatr Serv; 2008 May; 59(5):476. PubMed ID: 18451000
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia.
    Park T, Kuntz KM.
    Value Health; 2014 Jun; 17(4):310-9. PubMed ID: 24968989
    [Abstract] [Full Text] [Related]

  • 5. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
    Mladsi DM, Grogg AL, Irish WD, Lopez RB, Degen K, Swann A, Nimsch CT.
    Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206
    [Abstract] [Full Text] [Related]

  • 6. Cost of antipsychotic polypharmacy in the treatment of schizophrenia.
    Zhu B, Ascher-Svanum H, Faries DE, Correll CU, Kane JM.
    BMC Psychiatry; 2008 Apr 04; 8():19. PubMed ID: 18394168
    [Abstract] [Full Text] [Related]

  • 7. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y, Kim E, You M, Pikalov A, Tran QV.
    J Med Econ; 2009 Jun 04; 12(2):104-13. PubMed ID: 19527195
    [Abstract] [Full Text] [Related]

  • 8. What CATIE found: results from the schizophrenia trial.
    Swartz MS, Stroup TS, McEvoy JP, Davis SM, Rosenheck RA, Keefe RS, Hsiao JK, Lieberman JA.
    Psychiatr Serv; 2008 May 04; 59(5):500-6. PubMed ID: 18451005
    [Abstract] [Full Text] [Related]

  • 9. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
    Gianfrancesco F, Pesa J, Wang RH.
    J Manag Care Pharm; 2005 Apr 04; 11(3):220-30. PubMed ID: 15804206
    [Abstract] [Full Text] [Related]

  • 10. The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia.
    Chen L, McCombs JS, Park J.
    Value Health; 2008 Apr 04; 11(1):34-43. PubMed ID: 18237358
    [Abstract] [Full Text] [Related]

  • 11. Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.
    Law WL, Hui HY, Young WM, You JH.
    Int J Clin Pharmacol Ther; 2007 May 04; 45(5):264-70. PubMed ID: 17542348
    [Abstract] [Full Text] [Related]

  • 12. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.
    Montgomery JH, Byerly M, Carmody T, Li B, Miller DR, Varghese F, Holland R.
    Control Clin Trials; 2004 Dec 04; 25(6):598-612. PubMed ID: 15588746
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of long-acting risperidone injection versus alternative atypical antipsychotic agents in patients with schizophrenia in China.
    Yang L, Li M, Tao LB, Zhang M, Nicholl MD, Dong P.
    Value Health; 2009 Dec 04; 12 Suppl 3():S66-9. PubMed ID: 20586985
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M, Sapin C, Beillat M, Robinson P, Treur M.
    J Ment Health Policy Econ; 2015 Dec 04; 18(4):185-200. PubMed ID: 26729007
    [Abstract] [Full Text] [Related]

  • 15. Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis.
    Rajagopalan K, Wade S, Meyer N, Loebel A.
    Curr Med Res Opin; 2017 May 04; 33(5):813-820. PubMed ID: 28098496
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK .
    Davies A, Vardeva K, Loze JY, L'italien GJ, Sennfalt K, Baardewijk Mv.
    Curr Med Res Opin; 2008 Nov 04; 24(11):3275-85. PubMed ID: 18947458
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.
    Edwards NC, Locklear JC, Rupnow MF, Diamond RJ.
    Pharmacoeconomics; 2005 Nov 04; 23 Suppl 1():75-89. PubMed ID: 16416763
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators.
    N Engl J Med; 2005 Sep 22; 353(12):1209-23. PubMed ID: 16172203
    [Abstract] [Full Text] [Related]

  • 19. Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophrenia.
    Graham CN, Mauskopf JA, Lawson AH, Ascher-Svanum H, Bruhn D.
    Value Health; 2012 Jan 22; 15(1):55-64. PubMed ID: 22264972
    [Abstract] [Full Text] [Related]

  • 20. Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs.
    Yang YK, Tarn YH, Wang TY, Liu CY, Laio YC, Chou YH, Lee SM, Chen CC.
    Psychiatry Clin Neurosci; 2005 Aug 22; 59(4):385-94. PubMed ID: 16048443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.